Current SATVI news
UCT Health Sciences Faculty recently said farewell to Professor Greg Hussey, founding Director of SATVI, (Director: Vaccines for Africa and Interim Director of the HSF 2015-2016) upon his retirement.
SATVI author, Associate Professor Tom Scriba has co-authored a paper titled "Safety and Immunogenicity of Adenovirus 35 TB Vaccine Candidate in Adults with Active or Previous TB: a Randomized Trial" appearing in the American Journal of Respiratory and Critical Care Medicine.
SATVI authors Dr Adam Penn-Nicholson, Associate Professor Tom Scriba and Professor Mark Hatherill have published a paper titled "A novel blood test for tuberculosis prevention and treatment" appearing in the January edition of the South African Medical Journal.
Dr Sara Suliman, Postdoctoral Fellow has departed from SATVI to take up a postdoctoral fellowship at the Brigham and Women's Hospital at Harvard Medical School.
We invite applications from suitably qualified candidates for a vacancy as Senior Scientific Officer in the Immunology Laboratory of the South African Tuberculosis Vaccine Initiative. CLOSED
SATVI authors have published a paper titled "H1:IC31 vaccination is safe and induces long-lived TNF-a+IL-2+CD4 T cell responses in M. tuberculosis infected and uninfected adolescents: A randomized trial" appearing in the Vaccine Journal.
SATVI authors Associate Professor Tom Scriba and Dr Elisa Nemes have published a paper titled: "Teaching Advance Flow Cytometry in Africa: 10 Years of Lessons Learned appearing in the journal Cytometry Journal Part A.
The South African Tuberculosis Vaccine Initiative will be offering a limited number of bursaries to cover the Registration Fees associated with the SciMathUS Program, a university preparation program which is offered by the Stellenbosch University Centre for Pedagogy (SUNCEP). Closing date 18 January 2017.
SATVI authors, Mark Hatherill and Tom Scriba have contributed to a research paper titled "Correlates of tuberculosis risk: Predictive biomarkers for progression to active tuberculosis" appearing in the November edition of European Respiratory Journal.
We invite applications from suitably qualified candidates for a 24 month contract position as Laboratory Assistant at the Worcester Field Site Office. NOW CLOSED.
On Thursday 27 October 2016 SATVI Director, Associate Professor Mark Hatherill presented a paper titled "Developing a vaccine to prevent all forms of TB" at the The 47th Union World Conference on Lung Health.
On Thursday 27 October 2016, Associate Professor Tom Scriba, Deputy Director Immunology at the South African Tuberculosis Vaccine Initiative, presented a paper titled: "Searching for correlates of immunity and protection" at the 47th Union World Conference on Lung Health.